This paper highlights the status of the Indian biopharmaceutical industry and also makes a comparison with the global scenario. It also discusses the current situation regarding patenting biopharmaceuticals in India. [GIDR WP no. 168].

With a vast and diverse SME sector India’s industrialization owes much to the technological dynamism of enterprises. Various institutional interventions have been made to promote innovativeness in the sector, albeit, following economic reforms, it appears that the SME sector has not been...

There is a strong feeling among especially the West that India is becoming very innovative. The study will take the reader through the empirical evidence on whether this is indeed the case since the reform process of 1991. The actual innovative performance of India’s economy since...

Language alone can no longer be the basis for division of states. Issues such as size, governance, economic viability and recognition of new identities are equally important to consider the demands for reorganisation of states. Moreover, the social, economic and political context in which...

A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal...